M. Kulyk & Associates, LLC Zoetis Inc. Transaction History

M. Kulyk & Associates, LLC

$422 Million
Q1 2025

A detailed history of M. Kulyk & Associates, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, M. Kulyk & Associates, LLC holds 17,306 shares of ZTS stock, worth $2.74 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

17,306

Previous 36,509 52.6%

Holding current value

$2.74 Million

Previous $5.95 Million 52.1%

% of portfolio

0.67%

Previous 1.33%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$156.48 - $175.67 $3 Million - $3.37 Million	-19,203 Reduced 52.6%	17,306 $2.85 Million
Q4 2024 Feb 07, 2025	SELL	$162.24 - $194.42 $116,001 - $139,010	-715 Reduced 1.92%	36,509 $5.95 Million
Q3 2024 Nov 07, 2024	BUY	$172.58 - $196.48 $81,802 - $93,131	474 Added 1.29%	37,224 $7.27 Million
Q2 2024 Aug 05, 2024	BUY	$145.54 - $178.83 $416,244 - $511,453	2,860 Added 8.44%	36,750 $6.37 Million
Q1 2024 May 09, 2024	BUY	$165.67 - $199.94 $259,936 - $313,705	1,569 Added 4.85%	33,890 $5.73 Million
Q4 2023 Feb 08, 2024	BUY	$151.44 - $200.09 $186,119 - $245,910	1,229 Added 3.95%	32,321 $6.38 Million
Q3 2023 Nov 07, 2023	BUY	$167.14 - $192.77 $123,182 - $142,071	737 Added 2.43%	31,092 $5.41 Million
Q2 2023 Aug 08, 2023	BUY	$160.94 - $186.23 $87,390 - $101,122	543 Added 1.82%	30,355 $5.23 Million
Q1 2023 May 08, 2023	BUY	$145.48 - $175.02 $191,451 - $230,326	1,316 Added 4.62%	29,812 $4.96 Million
Q4 2022 Feb 08, 2023	BUY	$131.14 - $157.47 $126,287 - $151,643	963 Added 3.5%	28,496 $4.18 Million
Q3 2022 Nov 07, 2022	BUY	$148.29 - $182.55 $198,856 - $244,799	1,341 Added 5.12%	27,533 $4.08 Million
Q2 2022 Aug 05, 2022	BUY	$155.97 - $200.09 $254,543 - $326,546	1,632 Added 6.64%	26,192 $4.5 Million
Q1 2022 May 11, 2022	SELL	$181.39 - $234.03 $161,255 - $208,052	-889 Reduced 3.49%	24,560 $4.63 Million
Q4 2021 Jan 20, 2022	BUY	$193.69 - $247.03 $297,507 - $379,438	1,536 Added 6.42%	25,449 $6.21 Million
Q3 2021 Oct 21, 2021	BUY	$189.29 - $209.69 $178,500 - $197,737	943 Added 4.11%	23,913 $4.64 Million
Q2 2021 Jul 21, 2021	BUY	$155.9 - $187.99 $58,618 - $70,684	376 Added 1.66%	22,970 $4.28 Million
Q1 2021 Apr 29, 2021	BUY	$144.0 - $169.39 $610,416 - $718,044	4,239 Added 23.09%	22,594 $3.56 Million
Q4 2020 Feb 02, 2021	BUY	$157.07 - $174.35 $2.88 Million - $3.2 Million	18,355 New	18,355 $3.04 Million

Others Institutions Holding ZTS

# of Institutions

2,088

Shares Held

418M

Call Options Held

1.25M

Put Options Held

1.62M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $74B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kulyk & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M. Kulyk & Associates, LLC with notifications on news.

Account

M. Kulyk & Associates, LLC Zoetis Inc. Transaction History